Skip to content
healthcare.dev
Get a free key

Alfuzosin Hydrochloride extended release

NDC 69097-844, Alfuzosin Hydrochloride, tablet, from Cipla USA Inc..

Product NDC
69097-844
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA090284
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-844 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
69097-844-026909708440230 TABLET in 1 BOTTLE (69097-844-02)
69097-844-056909708440590 TABLET in 1 BOTTLE (69097-844-05)
69097-844-0769097084407100 TABLET in 1 BOTTLE (69097-844-07)
69097-844-1269097084412500 TABLET in 1 BOTTLE (69097-844-12)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3cc028d5-309f-4ce3-a2d7-5804ab57677d

Use it

Look up 69097-844 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-844 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-844. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.